EVGN:NASDAQ
Evogene Ltd
$0.73
arrow_upward
+2.08%(+0.015) 1D
May 29, 10:27:32 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.73
High
$0.73
Low
$0.73
Mkt. cap
6.32M
Avg. vol.
57.84K
Volume
4.91K
52-wk high
$2.42
52-wk low
$0.66
EPS
-$1.38
Beta
1.39
Shares outstanding
10.41M
No. of employees
52
Open
$0.73
High
$0.73
Low
$0.73
Mkt. cap
6.32M
Avg. vol.
57.84K
Volume
4.91K
52-wk high
$2.42
52-wk low
$0.66
EPS
-$1.38
Beta
1.39
Shares outstanding
10.41M
No. of employees
52
News stories
From sources across the web
TradingView
·
16 hours ago
EVGN: Revenue up 38% and adjusted EBITDA up 93% year-over-year, with key regulatory and financing milestones
The Legal Advocate
·
1 week ago
Evogene (EVGN) Q1 2026 Results Miss Estimates — EPS $-0.60 vs $-0.28 - ROE Trend Analysis
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
AI content may include mistakes. Learn more